DECEMBER 20238In My OpinionRosy offers personalized and holistic solutions for sexual wellness. Our research-backed offerings span a woman's entire lifespan, from menstruation through menopause and beyond. I started Rosy out of a genuine need. While practicing as an Ob/Gyn, I came across many patients with sexual health concerns that were not being fully addressed in the medical setting. As part of my ISSWSH fellowship in sexual wellness, I discovered real evidence-based solutions for women who face sexual challenges. However, they are often ignored due to embarrassment and lack of proper physician time and training. Over the past three years, Rosy has become home to the nation's largest network of healthcare professionals that support women's sexual health by focusing on getting the right information into the right hands, exactly when its needed. 8 percent of the nation's OB/GYNs now refer their patients to Rosy, and we serve over 150,000 women.Background-In 2022, Rosy collaborated with Roche Diagnostics via the Roche Creasphere Program to create and test an in-app series focused on encouraging cervical cancer education and screening. About 13,000 new cases of cervical cancer are diagnosed each year in the United States, and 4,000 women die of this cancer (a disproportionate number being women of color).Ryan Suk, Ph.D, The University of Texas Health Science Center in Houston, notes, Cervical cancer is preventable, but the incidence of the disease is higher than it should be, and there are large disparities in the rates of timely screening among women of different socio demographic groups.Unfortunately, the COVID-19 pandemic led to a substantial reduction in preventive healthcare, including HPV vaccinations and cervical cancer screenings, making this an urgent area of focus for the medical community.Given our aligned missions to improve the health of women, Rosy and Roche partnered to investigate the efficacy of the Rosy platform as an educational intervention and tool to improve healthcare behavior. The overarching goal was to increase the number of women who undergo cervical cancer screening and decrease the number of future cases of late-stage cervical cancer. Timeline + Sample Size-Working with a limited amount of time during which to complete the pilot, the Rosy team completed the design and engineering efforts module in two weeks and were able to continue to iterate the format in real time. They then collected data for the following nine weeks from May 26, 2022 until July 31st, 2022. In that time, 4,003 women on the Rosy platform, ranging from ages 17-84, completed the intervention.Method-The in-app module on the Rosy platform began with a pre-test to assess the THE ROSY APP'S SUCCESS IN CERVICAL CANCER EDUCATIONDr. Lyndsey Harper, CEO and Founder, RosyBy
< Page 7 | Page 9 >